NCT06994338: Tirzepatide for Alcohol Use Disorder
- State
- Under way
- Phase
- Phase 2
- People
- 42 planned
- Started
- 6 Oct 2025
- Primary completion
- 31 Aug 2026
- Arms
- Tirzepatide
- Results
- None posted
- 29 May 2025: Trial registered
- 6 Oct 2025: Trial started
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 2 registered trials.
Kind of treatment: Drug.
Also known as Arm 5- Tirzepatide, Mounjaro, Tirzepatide (LIPOLESS de Laboratorio de Productos Eticos C.E.I.S.A.), Zepbound.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.